Report
The opium poppy genome and morphinan production
- Li Guo1,2,3,*,
- Thilo Winzer4,*,
- Xiaofei Yang1,5,*,
- Yi Li4,*,
- Zemin Ning6,*,
- Zhesi He4,
- Roxana Teodor4,
- Ying Lu7,
- Tim A. Bowser8,
- Ian A. Graham4,†,
- Kai Ye1,2,3,9,†
- 1MOE Key Lab for Intelligent Networks and Networks Security, School of Electronics and Information Engineering, Xi’an Jiaotong University, Xi’an, 710049 China.
- 2The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, 710061 China.
- 3The School of Life Science and Technology, Xi’an Jiaotong University, Xi’an, 710049 China.
- 4Centre for Novel Agricultural Products, Department of Biology, University of York, York YO10 5DD, UK.
- 5Computer Science Department, School of Electronics and Information Engineering, Xi’an Jiaotong University, Xi’an, 710049 China.
- 6The Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.
- 7Shanghai Ocean University, Shanghai, 201306 China.
- 8Sun Pharmaceutical Industries Australia, Princes Highway, Port Fairy, VIC 3284, Australia.
- 9Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Fudan University, Shanghai, China.
- ↵†Corresponding author. Email: ian.graham{at}york.ac.uk (I.A.G.); kaiye{at}xjtu.edu.cn (K.Y.)
↵* These authors contributed equally to this work.
See allHide authors and affiliations
Science 19 Oct 2018:
Vol. 362, Issue 6412, pp. 343-347
DOI: 10.1126/science.aat4096
